…rules that are currently in effect suggest that making an exception available prevents the FFE from potentially losing issuer participation based on concerns the issuer will ultimately be able to address during or before the plan year, typically resulting in no potential harm to …

…er-based prior authorization system, including life-threatening adverse medical events, missed, or abandoned treatments, hospitalization, and permanent bodily damage. The provisions of this proposed rule, if finalized, could be an important step in reducing these adverse health e…

… instead interquartile ranges ( 90 FR 18099 ). The applicant summarized adverse events reported in Cauchy et al. (2011) and Crooks et al. (2022), as well as a multicenter retrospective cohort study and the AURLUMYN TM prescribing information. The applicant also referenced the NDA…

…(such as under the Inspector General Act of 1978). Nothing in this final rule prevents payers from sharing the requested data via these APIs, if technologically feasible, for appropriate purposes permitted by law. We encourage using these standards-based APIs for purposes beyond …

… a patient's health history. [ 3 4 5 ] This siloed nature of health care data prevents physicians, pharmaceutical companies, manufacturers, and payers from accessing and interpreting important data sets, instead, encouraging each group to make decisions based upon a part of the i…